Top insider buys and sells disclosed for Thursday By Investing.com

The article highlights a wave of insider activity across multiple companies, led by major buys at Hamilton Lane, Krispy Kreme, Cadiz, Polaryx Therapeutics, and Nakamoto, alongside large insider sales at Satellogic, CoreWeave, Stryker, and Arista Networks. The biggest disclosed sale was 10.0 million Satellogic shares for $97.7 million, while the largest purchase was Hartley Rogers’ 110,932 Hamilton Lane shares worth nearly $10 million. The content is primarily a recap of filings and trading activity rather than a catalyst-driven market event.

Analysis

The signal is split between “real money” confidence buys and balance-sheet/financing-driven selling. The most interesting long-side tells are the insider-led adds in DNUT, CDZI, and NAKA: these are names where insiders are effectively using size to defend a valuation reset, which often matters more in small caps than the absolute dollar amount. But the quality of the signal differs: the DNUT purchase is most credible because it comes from a high-conviction controller-type holder near depressed levels, while the biotech/turnaround buys look more like capital structure support and should be treated as event-driven rather than durable fundamental conviction.

The sell-side cluster is more important for portfolio construction than the buys. SATLW’s large disposition by a Mnuchin-linked vehicle looks like a supply overhang removal only if the market has already absorbed the float release; otherwise it can cap rallies for weeks because the buyer base must now digest a very concentrated block. ANET and SYK are less bearish on fundamentals than on valuation discipline: both are in the zone where insider selling tends to coincide with decelerating multiple expansion rather than imminent operational deterioration, so the edge is in fading upside chase rather than outright shorting.

The real second-order read is that high-quality, liquid compounders are seeing insiders monetize strength while weaker names are seeing insiders average down. That usually fits a late-cycle tape: investors are paying up for growth, but governance insiders are voting with their wallets that the marginal upside is narrower than the market implies. Near term, the cleanest expression is to avoid buying breakouts in ANET and SYK into strength and instead focus on relative-value exposure where insider buying aligns with depressed sentiment.

Contrarianly, the market may be underestimating how many of these sales are supply-management rather than negative fundamental calls; that matters because the pain trade is not a broad collapse, but a rotation from crowded winners into neglected balance-sheet-repair stories. The highest-risk name on the short side is SATLW because after a huge holder sale, a squeeze can still happen if liquidity is thin and momentum traders interpret the transaction as a one-off clean-up event. For the buys, the key risk is value traps: if the next 30-60 days do not bring tangible operating improvement or financing clarity, insider purchases can exhaust quickly and become dead-money drift.

Key Decisions for Investors

• Go long DNUT on a 2-6 week horizon only on weakness, not momentum; use a tight stop below the recent low because this is a high-beta mean-reversion trade with limited carry if the operating narrative does not stabilize.
• Avoid initiating new longs in ANET and SYK after strength; if already owned, trim 25-50% into rallies over the next 1-3 weeks because insider selling here is more consistent with upside compression than a hard fundamental break.
• Trade SATLW tactically from the short side only if borrow/liquidity are workable; use put spreads rather than outright short stock to define risk, since the catalyst path is a sharp squeeze if post-sale supply clears faster than expected.